On Demand Learning

30 Results

  • Q&A Session: Group Based Opioid Treatment

    Contains 3 Component(s), Includes Credits Recorded On: 04/28/2021

    ORN Webinar Series: This is a follow up Q&A Session: Group Based Opioid Treatment webinar. The webinar "Group Based Opioid Treatment" introduced a group-based format to deliver opioid use disorder (OUD) treatment incorporating medications and psychosocial programming. The number of people in need of OUD treatment continues to woefully outpace the availability of treatment providers. Providing treatment with multiple patients in a group-based setting is a strategy that can markedly expand access. Other benefits include enhancing patient recovery networks, improving provider satisfaction and financial viability. This webinar has been approved for 1 AOA Category 1-A CME credits, and AOA designates this for a maximum of 1 AMA PRA Category 1 Credits™.

  • Group Based Opioid Treatment

    Contains 3 Component(s), Includes Credits Recorded On: 04/21/2021

    ORN Webinar Series: This webinar will introduce a group-based format to deliver opioid use disorder (OUD) treatment incorporating medications and psychosocial programming. The number of people in need of OUD treatment continues to woefully outpace the availability of treatment providers. Providing treatment with multiple patients in a group-based setting is a strategy that can markedly expand access. Other benefits include enhancing patient recovery networks, improving provider satisfaction and financial viability. This webinar has been approved for 1 AOA Category 1-A CME credits, and AOA designates this for a maximum of 1 AMA PRA Category 1 Credits™.

  • Q&A Session: Buprenorphine Induction for High Potency Synthetic Opioid Users

    Contains 3 Component(s), Includes Credits Recorded On: 04/14/2021

    ORN Webinar Series: Q&A Session following a presentation on the use of injectable buprenophrine for the treatment of Opioid Use Disorder (OUD) in patients using Highly Potent Synthetic Opioids (HPSO). This webinar has been approved for 1 AOA Category 1-A CME credits, and AOA designates this for a maximum of 1 AMA PRA Category 1 Credits™.

  • Essentials: Stimulant Use Disorder

    Contains 4 Component(s), Includes Credits

    Review the diagnosis of stimulant use disorders.

  • Buprenorphine Induction for High Potency Synthetic Opioid Users

    Contains 3 Component(s), Includes Credits Recorded On: 04/07/2021

    ORN Webinar Series: Presentation on the use of injectable buprenophrine for the treatment of Opioid Use Disorder (OUD) in patients using Highly Potent Synthetic Opioids (HPSO). This webinar has been approved for 1 AOA Category 1-A CME credits, and AOA designates this for a maximum of 1 AMA PRA Category 1 Credits™.

  • Access to Buprenorphine Treatment for Opioid Use Disorder

    Contains 3 Component(s), Includes Credits Recorded On: 03/24/2021

    ORN Webinar Series: A lecture covering the current landscape of buprenorphine treatment availability and ongoing issues is making this medication available, accessible and sustainable for all in need. This webinar has been approved for 1 AOA Category 1-A CME credits, and AOA designates this for a maximum of 1 AMA PRA Category 1 Credits™.